Concepedia

Manuel Sequeira

MS

Statistics

Publications

18

Citations

1.2K

H-Index

15

Active since

1993

Affiliations

Synta Pharmaceuticals (United States)(Current)

Manuel Sequeira is an author at Synta Pharmaceuticals (United States) specializing in medicine, pharmacology, and oncology.

Publications per year

1993–2018

18

Publications

18

Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)

Julie Bernhardt, Leonid Churilov, Fiona Ellery et al. · Neurology · 2016 · 217 citations · Full text

, , +14

Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer

Jim Sang, Jaime Acquaviva, Julie C. Friedland et al. · Cancer Discovery · 2013 · 210 citations

, , +17

Overcoming Acquired BRAF Inhibitor Resistance in Melanoma via Targeted Inhibition of Hsp90 with Ganetespib

Jaime Acquaviva, Donald L. Smith, John-Paul Jimenez et al. · Molecular Cancer Therapeutics · 2014 · 102 citations

, , +14

Targeting KRAS-Mutant Non–Small Cell Lung Cancer with the Hsp90 Inhibitor Ganetespib

Jaime Acquaviva, Donald L. Smith, Jim Sang et al. · Molecular Cancer Therapeutics · 2012 · 98 citations

, , +14

Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models

David A. Proia, Jim Sang, Suqin He et al. · Investigational New Drugs · 2012 · 80 citations · Full text

, , +14

1–5 of 18